Methotrexate - Safe Backbone for the Treatment of Rheumatoid Arthritis

被引:0
作者
Krasselt, Marco [1 ]
机构
[1] Univ Leipzig, Med Clic 3, Med Ctr, Dept Endocrinol Nephrol & Rheumatol, Liebigstr 20, D-04103 Leipzig, Germany
关键词
Methotrexate; MTX; rheumatoid arthritis; safety; folic acid; intoxication; LOW-DOSE METHOTREXATE; INTERSTITIAL LUNG-DISEASE; FOLIC-ACID; TRIMETHOPRIM-SULFAMETHOXAZOLE; SUBCUTANEOUS METHOTREXATE; CAFFEINE CONSUMPTION; ORAL METHOTREXATE; DRUG-INTERACTIONS; CONCOMITANT USE; ADVERSE EVENTS;
D O I
10.2174/0115733971317122240626053727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methotrexate (MTX) is the primarily used disease-modifying antirheumatic drug (DMARD) for the treatment of Rheumatoid Arthritis (RA). MTX is a safe agent, even when used for years - provided that treatment is regularly monitored and prescribers follow some simple rules, such as prescribing tablets of a single strength only. Proper patient education contributes greatly to safe treatment. The knowledge of important pharmacologic facts, possible interactions, and clinical warning signs also helps to prevent or recognize intoxications early.Therefore, this review addresses key aspects regarding the safety of MTX. In this respect, it includes adverse events, possible interactions with frequently used drugs and details on the rare but life-threatening intoxication, e.g., due to erroneous daily intake.
引用
收藏
页码:169 / 181
页数:13
相关论文
共 122 条
  • [1] Methotrexate-induced pancytopenia: a case series of 46 patients
    Ajmani, Sajal
    Preet Singh, Yogesh
    Prasad, Shiva
    Chowdhury, Abhra
    Aggarwal, Amita
    Lawrence, Able
    Misra, Ramnath
    Mishra, Richa
    Agarwal, Vikas
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (07) : 846 - 851
  • [2] Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination
    Al-Khalili, Orwah
    Mikuls, Ted R.
    O'Dell, James R.
    England, Bryant R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (12) : 1429 - 1429
  • [3] Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination
    Al-Quteimat, O. M.
    Al-Badaineh, M. A.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (03) : 203 - 205
  • [4] Methotrexate and doxycycline interaction: a rare cause of pancytopenia
    Arslan, Ahmad
    Zain, Muhammad Abdullah
    Mukhtar, Maryam
    Ullah, Waqas
    Roomi, Sohaib
    [J]. BMJ CASE REPORTS, 2019, 12 (05)
  • [5] Atallah E, 2023, J HEPATOL, V78, P989, DOI 10.1016/j.jhep.2022.12.034
  • [6] Balkow F., 2010, Institute of Legal Medicine, Ludwig Maximilian University
  • [7] Benito-Garcia E, 2006, J RHEUMATOL, V33, P1275
  • [8] Accumulating Evidence for a Drug-Drug Interaction Between Methotrexate and Proton Pump Inhibitors
    Bezabeh, Shewit
    Mackey, Ann Corken
    Kluetz, Paul
    Jappar, Dilara
    Korvick, Joyce
    [J]. ONCOLOGIST, 2012, 17 (04) : 550 - 554
  • [9] BfArM Methotrexat, 2019, Dosierungsfehler
  • [10] Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity - a randomized controlled trial
    Bhargava, Mudit
    Kopp, Chirag Rajkumar
    Naidu, Shankar
    Dhibar, Deba Prasad
    Saroch, Atul
    Khadwal, Alka
    Narang, Tarun
    Jain, Siddharth
    Khullar, Aastha
    Leishangthem, Bidya
    Sharma, Aman
    Kumar, Susheel
    Sharma, Shefali
    Jain, Sanjay
    Dhir, Varun
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)